Form 8-K - Current report:
SEC Accession No. 0001104659-20-140370
Filing Date
2020-12-30
Accepted
2020-12-30 08:00:23
Documents
4
Period of Report
2020-12-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039447d3_8k.htm 8-K 17911
2 EXHIBIT 99.1 tm2039447d3_ex99-1.htm EX-99.1 9646
3 GRAPHIC tm2039447d3_8kimg001.jpg GRAPHIC 9031
4 GRAPHIC tm2039447d3_ex99-1img001.jpg GRAPHIC 8833
  Complete submission text file 0001104659-20-140370.txt   53662
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 201424076
SIC: 2834 Pharmaceutical Preparations